A Wernicke G, Yondorf M, Parashar B, Trichter S, Schwartz TH.
2015.
Response.. J Neurosurg. 123(4):1111-2.
Yondorf MZ, Schwartz TH, Boockvar JA, Pannullo S, Stieg P, Sabbas A, Pavese A, Trichter S, Nedialkova L, Parashar B et al..
2017.
Radiation Exposure and Safety Precautions Following 131Cs Brachytherapy in Patients with Brain Tumors.. Health Phys. 112(4):403-408.
Mahase SS, Navrazhina K, Schwartz TH, Parashar B, A Wernicke G.
2019.
Intraoperative brachytherapy for resected brain metastases.. Brachytherapy. 18(3):258-270.
Yondorf MZ, Faraz S, Smith AW, Sabbas A, Parashar B, Schwartz TH, A Wernicke G.
2020.
Dosimetric differences between cesium-131 and iodine-125 brachytherapy for the treatment of resected brain metastases.. J Contemp Brachytherapy. 12(4):311-316.
A Wernicke G, Hirschfeld CB, Smith AW, Taube S, Yondorf MZ, Parashar B, Nedialkova L, Kulidzhanov F, Trichter S, Sabbas A et al..
2017.
Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.. Int J Radiat Oncol Biol Phys. 98(5):1059-1068.
A Wernicke G, Smith AW, Taube S, Yondorf MZ, Parashar B, Trichter S, Nedialkova L, Sabbas A, Christos P, Ramakrishna R et al..
2017.
Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease.. J Neurosurg. 126(4):1212-1219.